SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Matinas BioPharma Holdings, Inc. (MTNB) News

Follow Matinas BioPharma Holdings, Inc. (MTNB) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 10 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol MTNB Asset equity Sector Markets 90 days 4 Last 0.93 Updated Sep 16, 2026, 09:25 PM UTC Open live news feed Open MTNB chart & news
H Matinas BioPharma Board Approves 1-For-15 Reverse Stock Split Effective September 28, 2026 On June 23, 2025, at the 2025 annual meeting of stockholders of Matinas BioPharma Holdings, Inc. (the "Company"), the stockholders approved the authorization of the Board of Directors (the "Board"), in its sole and absol LIVE | Sep 16, 2026, 09:25 PM UTC L Matinas BioPharma gets NYSE American non-compliance notice Matinas BioPharma Holdings said it received a notice on Aug. 31, 2026 from NYSE American LLC stating it is not in compliance with continued listing standards. EQUITY | Sep 04, 2026, 09:07 PM UTC L Matinas BioPharma gets NYSE American notice of noncompliance On Aug. 31, 2026, Matinas BioPharma received a NYSE American notice of noncompliance with Section 1003(a)(i). The exchange cited stockholders’ equity of $1.8 million versus a $2.0 million minimum and losses in recent yea EQUITY | Sep 04, 2026, 09:04 PM UTC L Matinas BioPharma receives NYSE American non-compliance notice Matinas BioPharma (MTNB) received a notice of non-compliance with NYSE American continued listing standards. EQUITY | Sep 04, 2026, 09:00 PM UTC L Top Small Cap Positive News Movers Premarket: LGHL: +120% Momentum Mover MTNB: +62% Sales Agreement Terminated DFNS: +59% SC 13D Filed BIYA Top Small Cap Positive News Movers Premarket: LGHL: +120% Momentum Mover MTNB: +62% Sales Agreement Terminated DFNS: +59% SC 13D Filed BIYA: +44% Momentum Mover VTAK: +29% Partners with 319 Golf Society and Named Exclusi EQUITY | Jul 27, 2026, 12:16 PM UTC L MTNB Gh power- Gh power equityholders to own 91% and matinas equityholders 9% of ghp international after closing Gh power - each matinas sha MTNB Gh power- Gh power equityholders to own 91% and matinas equityholders 9% of ghp international after closing Gh power - each matinas share to be converted into 0.1 ghp international share at closing - Gh power pursui EQUITY | Jul 13, 2026, 07:48 PM UTC L MTNB Gh power, the pioneering clean energy and critical Materials company, to go public through business combination with matinas Biopharma MTNB Gh power, the pioneering clean energy and critical Materials company, to go public through business combination with matinas Biopharma Gh power - Gh power international to become public Parent company of Gh power an EQUITY | Jul 13, 2026, 07:46 PM UTC H Matinas BioPharma to Merge With GH Power; Signs Deal to Sell Subsidiary, Lead Product Candidate () -- Matinas BioPharma (MTNB) said Monday it has agreed to a definitive business combination with GH Power, a developer of proprietary modular reactor systems. Under the terms, GH Power and Matinas will become subsidiar MNA | Jul 13, 2026, 01:03 PM UTC L 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Can Fite Biopharma (AMEX: CANF ) stock moved upwards by 52.0% to $4.52 during Wednesday's pre-market session. The company's market cap stands at $6.3 million. Atlantic International (NASDAQ: ATLN ) shares rose 17 EQUITY | Jul 01, 2026, 12:05 PM UTC M MTNB: Noncompliance Letter Matinas BioPharma obtains NYSE noncompliance letter REGULATION | Jun 26, 2026, 11:20 PM UTC